Augma Biomaterials

Augma Biomaterials Overview

Augma Biomaterials is dedicated to the development, production, and marketing of synthetic bone substitutes for the dental market. The companys 3D Bond (biphasic calcium sulfate) functions as a scaffold for bone regeneration in dental procedures and is intended to fill, augment, or reconstruct bony defects in the oral and maxillofacial region. Augmas Bond Apatite combines 3D Bond with a formula of hydroxyapatite granules to create a cement-based osteoconductive composite. Bond Apatite is a synthetic bone substitute used for bone reconstruction in a range of dental applications and is intended for filling, augmenting, and reconstructing a wide variety of defects in the maxillofacial bones. The product is FDA cleared and CE approved.

Latest News

Jan 24, 2019 · www.prnewswire.com

growth-positive

Inventor of Dental Material Technology That Regrows Bone Is Edison Awards Finalist

Dr. Amos Yahav, founder of Augma Biomaterials, has been selected as a finalist for the 2019 Edison Awards for his invention of Bond Apatite, a new dental material technology that regenerates a patients own natural bone following implants and other complex oral procedures. Bond Apatite is a cement-based material that is injected into the areas where implants or oral bone augmentation restoration procedures are performed, causing a patients natural bone to regenerate post-procedure. The product has been successfully used in hundreds of thousands of procedures by thousands of dentists and dental specialists around the world.

Customers

Funding

Team Members

2

Employees: 11-50

Web & Social Links

Locations

Alon Hatavor 20, Keisarya, Israel

1989 Englishtown Road, Monroe Township, NJ, USA

Photos & Videos

8 item(s)

Augma Biomaterials Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info